Accuracy of conventional cytology: results from a multicentre screening study in India

Author:

Sankaranarayanan R1,Thara S2,Sharma A3,Roy C4,Shastri S5,Mahé C6,Muwonge R7,Fontanière B8,

Affiliation:

1. Scientist/Medical Officer, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon cedex 08, France

2. Assistant Professor of Pathology, Regional Cancer Centre, Trivandrum 695011, India

3. Pathologist, Bhagwan Mahaveer Cancer Hospital & Research Centre, Jawaharlal Nehru Marg, Jaipur 302017, India

4. Head of Pathology, Chittaranjan National Cancer Institute, S.P. Mukherjee Road, Kolkata 700026, India

5. Head and Professor of Preventive Oncology, Tata Memorial Centre, Ernst Borges Marg, Parel, Mumbai 400012, India

6. Scientist/Statistician, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon cedex 08, France

7. Statistician, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon cedex 08, France

8. Associate Professor of Cytology, Centre Léon Bérard, Lyon, Lyon, France

Abstract

Objective: We conducted a multi-centre cross-sectional study in India to evaluate the accuracy of conventional cytology to detect high-grade squamous intraepithelial lesions (HSIL). Setting: Cross-sectional studies in Jaipur, Kolkata, Mumbai and Trivandrum, India, during 1999-2003. Methods: A common protocol and questionnaire were used to test 22,663 women aged 25-65 years with conventional cytology in five cross-sectional studies. Three thresholds were used to define test positivity: atypical squamous cells of uncertain significance (ASCUS), low-grade squamous intra-epithelial lesion (LSIL), or HSIL. All screened women were investigated with colposcopy, and biopsies were taken when necessary. The reference standard for final disease status was histology or negative colposcopy. Data from the studies were pooled to evaluate the test characteristics for the detection of histologically confirmed HSIL. Results: The test positivity rates of cytology were 8.8% at ASCUS, 6.2% at LSIL and 1.8% at HSIL thresholds, and 355 women had histologically confirmed HSIL while 74 had invasive cancer. The pooled sensitivity, specificity, positive and negative predictive values at ASCUS threshold were 64.5%, 92.3%, 11.8% and 99.4% respectively. The corresponding values at LSIL threshold were 58.0%, 94.9%, 15.2% and 99.3%, while at the HSIL threshold they were 45.4%, 99.2%, 46.3% and 99.1%. The sensitivity varied between 37.8-81.3% at ASCUS , 28.9-76.9% at LSIL and 24.4-72.3% at HSIL thresholds. A significantly low sensitivity was observed in women aged 25-39 years (p<0.001). The wide variation in sensitivity across study sites persisted even after age standardisation. Conclusion: The sensitivity of cytology varied widely between the study sites. Findings from our study and other reviews indicate that sustained efforts in improving sampling, preparation and reading of cytological specimens and improvements in clinical judgement are essential to achieve concurrently high sensitivity and specificity.

Publisher

SAGE Publications

Subject

Public Health, Environmental and Occupational Health,Health Policy

Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Cancer Screening in India;Tata Memorial Centre Textbook of Oncology;2024

2. Internal Quality Control Indicators in Cervical Smear Screening- Report From a Tertiary Care Center, India;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2023

3. Smart Intelligent System for Cervix Cancer Image Classification Using Google Cloud Platform;Enabling Technologies for Effective Planning and Management in Sustainable Smart Cities;2023

4. Efficacy of Hospital-based Cervical Cytology Screening: A 5-year Audit in a Tertiary Care Clinical Center;Journal of South Asian Federation of Obstetrics and Gynaecology;2022-11-16

5. Deep learning based cervical screening by the cross-modal integration of colposcopy, cytology, and HPV test;International Journal of Medical Informatics;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3